Eli Lilly secures patent win against Dr Reddy’s

A US court handed victory to Eli Lilly late last week after finding that a drug for which Dr Reddy’s is seeking approval would infringe a patent covering cancer treatment Alimta (pemetrexed for injection).

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Americas

Fed Circ affirms Eli Lilly victories over cancer drugs

13 August 2019 The US Court of Appeals for the Federal Circuit last week affirmed two findings that Dr Reddy’s and Hospira had infringed Eli Lilly’s cancer drug Alimta.

Americas

Eli Lilly collaborates with AC Immune to develop Alzheimer’s treatment

12 December 2018 Global pharmaceutical company Eli Lilly has entered into a licence and collaboration agreement with Swiss biotechnology company AC Immune.

Americas

Eli Lilly wins Alimta dispute against Sun

3 May 2017 A judge at the US District Court for the Southern District of Indiana has handed down a final judgment in a patent dispute between Eli Lilly and Sun Pharmaceutical favouring Eli Lilly.

More on this story

Americas

Fed Circ affirms Eli Lilly victories over cancer drugs

13 August 2019 The US Court of Appeals for the Federal Circuit last week affirmed two findings that Dr Reddy’s and Hospira had infringed Eli Lilly’s cancer drug Alimta.

Americas

Eli Lilly collaborates with AC Immune to develop Alzheimer’s treatment

12 December 2018 Global pharmaceutical company Eli Lilly has entered into a licence and collaboration agreement with Swiss biotechnology company AC Immune.

Americas

Eli Lilly wins Alimta dispute against Sun

3 May 2017 A judge at the US District Court for the Southern District of Indiana has handed down a final judgment in a patent dispute between Eli Lilly and Sun Pharmaceutical favouring Eli Lilly.

More on this story

Americas

Fed Circ affirms Eli Lilly victories over cancer drugs

13 August 2019 The US Court of Appeals for the Federal Circuit last week affirmed two findings that Dr Reddy’s and Hospira had infringed Eli Lilly’s cancer drug Alimta.

Americas

Eli Lilly collaborates with AC Immune to develop Alzheimer’s treatment

12 December 2018 Global pharmaceutical company Eli Lilly has entered into a licence and collaboration agreement with Swiss biotechnology company AC Immune.

Americas

Eli Lilly wins Alimta dispute against Sun

3 May 2017 A judge at the US District Court for the Southern District of Indiana has handed down a final judgment in a patent dispute between Eli Lilly and Sun Pharmaceutical favouring Eli Lilly.

More features

Life sciences leaders recognised at LSPN Awards USA 2025

UK-India trade deal is ‘a missed opportunity for UK pharma’, says industry body

LSPN: Counsel grapple with AI’s impact on training and critical thinking

'Nothing can stand in the way of our work': Ukraine resumes IP system

LSPN: Trump's policy storm causing chaos and confusion

Taylor Wessing expands in Europe with Paris team

LSPN: Using ‘the patentee’s friend’ in Section 112 claims

ResMed voids sleep apnoea tech patent at PTAB

Eli Lilly secures patent win against Dr Reddy’s

More on this story

Editor's picks

Editor's picks

More on this story

More on this story

More features